ymabs.com (YMAB) Cash Funds Calculated per Share

Corporate emblem and logo of Y-mAbs Corp (YMAB)

Y-mAbs Therapeutics revenues are based on the commercialization of Danyelza and the development of radioimmunotherapy. Actual cash per share reflects liquidity dynamics, with the indicator standing at 1.38. The company develops life-saving treatments for rare pediatric tumors, complementing its strategy with targeted licensing of distribution rights for its antibodies across various global regions.

ymabs.com (YMAB) - Cash per Single Share from 07/04/2022 to 09/27/2025

Comprehensive metric breakdowns and analytics for Y-mAbs Corp (YMAB)

- stock quotes and analyst forecast:
- cash position and cash flow details:
Comprehensive company analysis:YmAbs - YMAB
Flagship merchandise of YmAbs

This indicator reflects the volume of liquid assets per common share, allowing for an assessment of the real capital cushion and the investor's protection against bankruptcy. Analyzing the cash per share trend confirms the financial stability of Y-mAbs Therapeutics (YMAB), whose exceptional pricing power in the neuroblastoma therapy segment ensures a steady cash flow and high business autonomy.

Key competitors

Cash Funds per Single Share ONC (BeiGene Corp)|Cash per Single Share HALO (Halozyme Therapeutics, Inc.)|Cash per Share Revolution Medicines, Inc. (RVMD)|Cash per Share AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cash on Hand per Share|URGN - Cash Funds per Share|Bicara Bio - Cash Calculated per Single Share|PSNL: Cash per Share|Cash Funds per Single Share ERAS|Cash per Single Share DCTH|Cash per Single Share Aura Biosciences (AURA)|Cash Funds per Share Candel Therapeutics Inc. (CADL)|Cash per Single Share Accuray, Inc. ARAY|Cash Funds per Share sellaslifesciences.com SLS|Amount of Cash per Share ACTU|CTOR - Cash Funds per Share|Cash Funds Calculated per Share tuhurabio.com HURA|Protara Therapeutics, Inc. (TARA) - Cash Funds per Share|FATE: Cash Calculated per Single Share|WHWK (Aadi Bioscience, Inc.) - Cash per Share|TCRX (TScan Therapeutics) - Cash Calculated per Single Share|Cash Funds per Share Champions Oncology (CSBR)|Cash Funds Calculated per Share XBiotech USA|Cash Funds per Share CEL-SCI CVM|OS Therapies, Inc. (OSTX) - Cash on Hand per Share|RADX - Cash Funds per Share|ARTV - Cash per Share|Adlai Nortye Ltd (ANL) - Cash Funds per Share|Veru Pharma - Amount of Cash per Share|Cash Funds per Share Tempest Therapeutics Corp|Cash Funds per Single Share XLO (Xilio Therapeutics, Inc.)|Cash per Share RENB|MURA (Mural Oncology) - Amount of Cash per Share|Cash per Share KAPA (Kairos Pharma Ltd)|OKUR: Cash Funds per Single Share|GDTC: Cash per Single Share|CRIS - Cash per Share|APLM: Cash per Share|Cash on Hand per Share tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Cash per Share|Cash per Share Genprex Inc.|Cash per Share CLDI|Cash per Single Share Sunshine Biopharma, Inc. SBFM|Cash per Share XBIO (Xenetic Biosciences)|Amount of Cash per Share SLRX|PPBT - Cash Funds per Share|AONC (aoncology.com) - Cash Funds per Single Share|BGNE: Cash per Share|Checkpoint Therapeutics Inc (CKPT) - Cash per Share|ELEV (Elevation Oncology Inc.) - Cash per Share|icadmed.com (ICAD) - Cash Funds Calculated per Share|Cash per Share IKNA|NTBL (Notable Labs) - Amount of Cash per Share|Cash per Share VIRX (Viracta Therapeutics)|Cash Funds Calculated per Share MorphoSys AG (MOR)|NAYA Biosciences Corp - Cash per Share|Cash on Hand per Share ascentage.com